Categories: News

Meridian Bioscience to Participate in H.C. Wainwright Global Life Sciences 2021 Virtual Conference

CINCINNATI, March 04, 2021 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, announced today its participation in the H.C. Wainwright Global Life Sciences 2021 Virtual Conference. Jack Kenny, Chief Executive Officer, will pre-record a presentation that will be available on March 9, 2021.

A link to access the pre-recorded presentation will be available in the Events & Presentations section of the Company’s Investor Relations website at https://investor.meridianbioscience.com/ for 90 days.

For additional information on the H.C. Wainwright Global Life Sciences 2021 Virtual Conference, please visit www.hcwevents.com/globalconference/.

About Meridian Bioscience, Inc.
Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com.

Contact:
Charlie Wood
Vice President – Investor Relations
Meridian Bioscience, Inc.
Phone: +1 513.271.3700
Email: mbi@meridianbioscience.com

Staff

Recent Posts

HealthArc Joins athenahealth’s Marketplace Program to Streamline Remote Care, Patient Outcomes, and Billing Process

HealthArc's unified remote care management platform integrates with athenahealth'sEHR to automate clinical documentation, enhance patient…

9 hours ago

AI/ML Innovations Inc. Enters Market Awareness Agreement

VICTORIA, BC / ACCESSWIRE / November 27, 2024 / AI/ML Innovations Inc. ("AI/ML" or the…

9 hours ago

Theralase(R) Release’s 3Q2024 Financial Statements

TORONTO, ON / ACCESSWIRE / November 27, 2024 / Theralase® Technologies Inc. (" Theralase® "…

9 hours ago

Top NY Plastic Surgeon Dr. Rubinstein Chosen to Train New Advanced BOTOX(R) Cosmetic Technique for Platysma Bands After FDA Approval

Renowned expert Dr. Rubinstein to train practitioners on new BOTOX® technique for smoother neck contours…

12 hours ago

AAMA Installs Loxie Kistler, EdD, MS, BSN, RN, CMA (AAMA), CHUC, as 2024–2026 Secretary

GRAND RAPIDS, MI / ACCESSWIRE / November 27, 2024 / The American Association of Medical…

12 hours ago